RxDoctor Payments DataLook up a doctor →

David Kuo, MD

Internal Medicine · Salt Lake City, UTNPI 1508881640

Payments from drug & device makers

$7,960in general payments, 2019–2025

Across 495 payments — averaging $16.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$803
  • Lilly USA, LLC$757
  • Boehringer Ingelheim$721
  • AbbVie$617
  • Amgen$587
  • Sanofi-aventis U.S. LLC$327
  • plus $4K from 43 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck58$803
Lilly USA, LLC52$757
Boehringer Ingelheim39$721
AbbVie(2 entities)39$617
Amgen41$587
Sanofi-aventis U.S. LLC23$327
Abbott24$309
Astellas Pharma US Inc18$304
Corcept Therapeutics12$284
Xeris Pharmaceuticals, Inc.13$276
Gilead12$249
Viiv Healthcare Company10$221
AstraZeneca14$220
Novartis12$219
GSK12$192
Bayer9$156
Pfizer10$143
Novo Nordisk10$143
Johnson & Johnson(2 entities)9$141
Dexcom, Inc.7$127
Insmed, Inc.8$121
Medtronic6$93
Paratek Pharmaceuticals, Inc.5$77
Amarin Pharma, Inc.5$76
Lifescan, Inc.5$70
Sanofi Pasteur Inc.5$70
E.r. Squibb & Sons, L.L.C.4$61
Ascensia Diabetes Care US Inc.3$60
Biohaven Pharmaceuticals, Inc.2$51
Edwards Lifesciences2$46
Boston Scientific3$45
Daiichi Sankyo Inc.2$43
Kyowa Kirin, Inc.2$39
Tetraphase Pharmaceuticals, Inc.2$38
Mylan Specialty L.p.2$36
Lucid Diagnostics Inc.2$27
Esperion Therapeutics, Inc.1$23
Sequel Med Tech, LLC1$21
Actelion Pharmaceuticals US, Inc.1$20
Tandem Diabetes Care, Inc.1$19
Kowa Pharmaceuticals America, Inc.1$17
Mannkind Corporation1$17
Inspire Medical Systems, Inc.1$15
Antares Pharma, Inc.1$15
Cequr Corporation1$14
Qiagen, LLC1$14
Ferring Pharmaceuticals Inc.1$13
Melinta Therapeutics, LLC1$13
Exact Sciences1$13

How this compares

$7,960 in reported general payments places this provider in the 90th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$200,666
Medicare patients
386
Services billed
3,370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Salt Lake City

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →